About Samsung Bioepis
Samsung Bioepis is a biopharmaceutical company that specializes in the development and commercialization of biosimilars. Founded in 2012 as a joint venture between Samsung Biologics and Biogen, the company aims to provide high-quality, affordable biologic medicines to patients worldwide. Samsung Bioepis leverages advanced biomanufacturing technologies and a robust pipeline of biosimilar products to address the growing demand for effective treatments in various therapeutic areas, including oncology, immunology, and diabetes. The company is committed to innovation and quality, ensuring that its products meet stringent regulatory standards. With a focus on patient access and healthcare sustainability, Samsung Bioepis is positioned to play a significant role in the global biopharmaceutical landscape.
Company facts
- Industry
- Biopharmaceuticals
- Sub-industries
- Biosimilars, Biologics, Pharmaceuticals, Healthcare, Biotechnology
- Location
- Incheon, South Korea
- Employees
- 1–10
- Revenue (USD)
- <1M
Products and services
Open Samsung Bioepis in GlobalDeal Is this your company? Update the details for free
More Biopharmaceuticals companies in South Korea
- Celltrion Skincure
Celltrion Skincure is a South Korean biopharmaceutical company specializing in the development and manufacturing of innovative skincare products. The company is a subsidiary of…